Cita APA

Mirza, M. R., Bjørge, L., Marmé, F., Christensen, R. D., Gil Martin, M., Auranen, A., . . . Sehouli, J. (2025). Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial.

Citación estilo Chicago

Mirza, Mansoor R., et al. Palbociclib Plus Letrozole in Estrogen Receptor-positive Advanced/recurrent Endometrial Cancer: Double-blind Placebo-controlled Randomized Phase II ENGOT-EN3/PALEO Trial. 2025.

Cita MLA

Mirza, Mansoor R., et al. Palbociclib Plus Letrozole in Estrogen Receptor-positive Advanced/recurrent Endometrial Cancer: Double-blind Placebo-controlled Randomized Phase II ENGOT-EN3/PALEO Trial. 2025.